Implementation of an Opt-Out Testing and Rapid Diagnostic Strategy for Syphilis and HIV in Pregnant Patients Presenting to the Emergency Department
Sponsored by The University of Texas Health Science Center, Houston
About this study
The purpose of this study is to evaluate infection detection and treatment initiation rates for syphilis and HIV before and after integration of the Chembio DPP® HIV-Syphilis rapid POC test into an ongoing Emergency Department (ED) testing program and to determine whether dual rapid testing improves early initiation of HIV therapy in pregnant patients with newly identified HIV infection.
Where this study is enrolling
- I'm interested
The University of Texas Health Science Center at Houston
Houston, Texas
Who can participate
Inclusion criteria
- ✓Pregnancy
- ✓Presentation to the ED or obstetrical triage during the index pregnancy.
- ✓No established prenatal care (≤1 visit) and/or no documented HIV or syphilis testing during the current pregnancy.
Exclusion criteria
- ✕Medically unstable or critically ill at the time of ED presentation.
- ✕Incarcerated at the time of ED presentation.
- ✕Decline participation in testing (opt-out) or refuse survey participation.
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.